Shinpei Kawaoka
Overview
Explore the profile of Shinpei Kawaoka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
1304
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maeshima Y, Kataoka T, Vandenbon A, Hirata M, Takeuchi Y, Suzuki Y, et al.
EBioMedicine
. 2024 Aug;
107:105271.
PMID: 39173531
Background: Breast cancer cells suppress the host immune system to efficiently invade the lymph nodes; however, the underlying mechanism remains incompletely understood. Here, we aimed to comprehensively characterise the effects...
2.
Oguchi A, Suzuki A, Komatsu S, Yoshitomi H, Bhagat S, Son R, et al.
Science
. 2024 Jul;
385(6704):eadd8394.
PMID: 38963856
Transcribed enhancer maps can reveal nuclear interactions underpinning each cell type and connect specific cell types to diseases. Using a 5' single-cell RNA sequencing approach, we defined transcription start sites...
3.
Nakamura Y, Saldajeno D, Kawaguchi K, Kawaoka S
Cancer Sci
. 2024 Jan;
115(3):715-722.
PMID: 38254286
Cancer cachexia is a complex, multifaceted condition that negatively impacts the health, treatment efficacy, and economic status of cancer patients. The management of cancer cachexia is an essential clinical need....
4.
Saldajeno D, Kawaoka S, Masuda N, Tanaka S, Bando H, Nishimura T, et al.
Br J Cancer
. 2024 Jan;
130(6):1023-1035.
PMID: 38238427
Background: Triple-negative breast cancer (TNBC) is the most heterogeneous breast cancer subtype. Partly due to its heterogeneity, it is currently challenging to stratify TNBC patients and predict treatment outcomes. Methods:...
5.
Yoda M, Mizuno R, Izumi Y, Takahashi M, Bamba T, Kawaoka S
J Biochem
. 2023 Apr;
174(1):89-98.
PMID: 37014628
Nicotinamide-N-methyltransferase (NNMT) is an enzyme that consumes S-adenosyl-methionine (SAM) and nicotinamide (NAM) to produce S-adenosyl-homocysteine (SAH) and 1-methylnicotinamide (MNAM). How much NNMT contributes to the quantity regulation of these four...
6.
He C, Konishi R, Harata A, Nakamura Y, Mizuno R, Yoda M, et al.
Front Immunol
. 2023 Feb;
14:1097788.
PMID: 36817472
Cancers induce the production of acute phase proteins such as serum amyloid alpha (SAA) in the liver and cause inflammation in various host organs. Despite the well-known coincidence of acute...
7.
Vandenbon A, Mizuno R, Konishi R, Onishi M, Masuda K, Kobayashi Y, et al.
Commun Biol
. 2023 Jan;
6(1):97.
PMID: 36694005
The spatially organized gene expression program within the liver specifies hepatocyte functions according to their relative distances to the bloodstream (i.e., zonation), contributing to liver homeostasis. Despite the knowledge that...
8.
Nagahata Y, Masuda K, Nishimura Y, Ikawa T, Kawaoka S, Kitawaki T, et al.
Blood
. 2022 Sep;
140(24):2611-2625.
PMID: 36112959
Blood cells are thought to have emerged as phagocytes in the common ancestor of animals followed by the appearance of novel blood cell lineages such as thrombocytes, erythrocytes, and lymphocytes,...
9.
Mizuno R, Hojo H, Takahashi M, Kashio S, Enya S, Nakao M, et al.
Nat Commun
. 2022 Jun;
13(1):3346.
PMID: 35705545
Cancers disrupt host homeostasis in various manners but the identity of host factors underlying such disruption remains largely unknown. Here we show that nicotinamide-N-methyltransferase (NNMT) is a host factor that...
10.
Nojiri T, Arai M, Suzuki Y, Kumazoe M, Tokudome T, Miura K, et al.
Oncotarget
. 2022 Apr;
13:551-552.
PMID: 35359748
[This retracts the article DOI: 10.18632/oncotarget.18032.].